ArticlePloS one2026
Olfactory bulbectomy induces neurobiological alterations in the prefrontal cortex and hyperlocomotion in male rats.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Early-stage olfactory bulbectomy induces hyperlocomotion with increased astrocyte and microglial density in the prefrontal cortex of male rats.Brain structure & function · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Major depressive disorder (MDD) is a leading cause of disability and encompasses various subtypes, including agitated depression which is associated with psychomotor agitation and elevated suicide risk. Although the olfactory bulbectomy (OBX) model has been extensively utilized to study depression-related behaviors, most studies have focused on the hippocampus, leaving the role of the prefrontal cortex (PFC) less explored. In this study, we examined the behavioral responses to novelty in the open field test and examined glial and neuronal alterations in the PFC of OBX rats. Our findings revealed that OBX induced hyperlocomotion, consistent with agitated depression. At the cellular level, OBX selectively increased the number of glial fibrillary acidic protein (GFAP)-positive astrocytes in the PFC. These modifications were accompanied by elevated nitric oxide (NO) levels, enhanced c-Fos expression, and a reduction in pyramidal neuron spine density. These findings represent the first integrated evidence of concurrent glial proliferation, NO dysregulation, and impaired neuronal plasticity in the PFC following OBX. Collectively, our results highlight the translational relevance of OBX as a model of agitated depression and point to astrocytic dysfunction and glial-neuronal interaction in the PFC as key contributors to synaptic and behavioral abnormalities in MDD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.